ATE356199T1 - Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation - Google Patents

Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation

Info

Publication number
ATE356199T1
ATE356199T1 AT97944670T AT97944670T ATE356199T1 AT E356199 T1 ATE356199 T1 AT E356199T1 AT 97944670 T AT97944670 T AT 97944670T AT 97944670 T AT97944670 T AT 97944670T AT E356199 T1 ATE356199 T1 AT E356199T1
Authority
AT
Austria
Prior art keywords
myoblasts
fusion
promoting
transplantation
transplanted
Prior art date
Application number
AT97944670T
Other languages
English (en)
Inventor
Jacques P Tremblay
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21844898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE356199(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Laval filed Critical Univ Laval
Application granted granted Critical
Publication of ATE356199T1 publication Critical patent/ATE356199T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT97944670T 1996-10-18 1997-10-17 Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation ATE356199T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2869296P 1996-10-18 1996-10-18

Publications (1)

Publication Number Publication Date
ATE356199T1 true ATE356199T1 (de) 2007-03-15

Family

ID=21844898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944670T ATE356199T1 (de) 1996-10-18 1997-10-17 Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation

Country Status (7)

Country Link
US (3) US20020012657A1 (de)
EP (1) EP0946713B1 (de)
AT (1) ATE356199T1 (de)
AU (1) AU4613397A (de)
CA (1) CA2269096C (de)
DE (1) DE69737460T2 (de)
WO (1) WO1998017784A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299201B1 (it) * 1998-05-08 2000-02-29 San Raffaele Centro Fond Fibroblasti modificati geneticamente e loro uso
US6284242B1 (en) * 1999-04-16 2001-09-04 Regents Of The University Of Michigan Method for enhancing myoblast migration and invasion in the context of gene therapy
US6673604B1 (en) 1999-07-23 2004-01-06 Diacrin, Inc. Muscle cells and their use in cardiac repair
US20030113301A1 (en) * 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
US20040158289A1 (en) * 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
US7627373B2 (en) * 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
JP2008537942A (ja) * 2005-03-31 2008-10-02 マイトジェン， インコーポレイテッド 心疾患のための処置
WO2006122005A2 (en) 2005-05-09 2006-11-16 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
AU2017351638A1 (en) * 2016-10-26 2019-06-13 Genea Biocells USA (Holdings), Inc. Improved generation of muscle lineage cells and therapeutic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040815B2 (ja) * 1989-11-24 2000-05-15 モナッシュ・ユニバーシティ 随伴細胞に及ぼす白血病抑制因子の増殖作用
WO1991012329A2 (en) * 1990-02-12 1991-08-22 Board Of Regents, The University Of Texas System Satellite cell proliferation in adult skeletal muscle
US5833978A (en) * 1995-03-16 1998-11-10 Universite Laval Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of recessive myopathies like muscular dystrophy, for improving transplantation success
US6284242B1 (en) 1999-04-16 2001-09-04 Regents Of The University Of Michigan Method for enhancing myoblast migration and invasion in the context of gene therapy

Also Published As

Publication number Publication date
EP0946713B1 (de) 2007-03-07
AU4613397A (en) 1998-05-15
US20020182193A1 (en) 2002-12-05
CA2269096A1 (en) 1998-04-30
US7189391B2 (en) 2007-03-13
CA2269096C (en) 2009-12-15
EP0946713A1 (de) 1999-10-06
DE69737460D1 (de) 2007-04-19
US20020012657A1 (en) 2002-01-31
US20070178077A1 (en) 2007-08-02
WO1998017784A1 (en) 1998-04-30
DE69737460T2 (de) 2008-04-10

Similar Documents

Publication Publication Date Title
ATE356199T1 (de) Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation
Tholpady et al. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro
Burrow et al. Human adipose‐derived stem cells exhibit enhanced proliferative capacity and retain multipotency longer than donor‐matched bone marrow mesenchymal stem cells during expansion in vitro
CA2339182A1 (en) Improvement of cardiac function by mesenchymal stem cell transplantation
ATE79720T1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
ATE250664T1 (de) In vitro reifen von oozyten mit inhibitin/activin kombinationen
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
EA200200698A1 (ru) Способ выделения рнк из фиксированных формалином и залитых в парафин образцов ткани
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
DK1115840T3 (da) Afstamningsspecifikke celler og progenitorceller
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
SE8504872D0 (sv) Selekteringsforfarande och medel herfor
DE69636545D1 (de) Gefrierkonservierte hepatocyten und verfahren für ihre herstellung
ATE258593T1 (de) Verfahren zur gefriertrocknung von verschiedenen mikroorganismen
ATE123069T1 (de) Verfahren zur herstellung von humanem faktor viii und dessen analogen.
DE69714775D1 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
DE60038630D1 (de) Verfahren zur ex vivo bildung von säugetier-knochen und dessen verwendungen
KR880007714A (ko) 구군 식물의 증식방법
HK1041442A1 (zh) 改善胚胎腎移植物功能的組合物及方法
Smith et al. A new creativity test.
O'Brien et al. Recent advances in and therapeutic potential of muscle‐derived stem cells
ATE190648T1 (de) Verfahren zum züchten von bipolar adhärierten hepatozyten
ATE106447T1 (de) Verfahren zur gewinnung der protease von endothia parasitica.
DE69019843D1 (de) Verfahren zur Herstellung von NADH-Oxydase.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties